In situ assembly of an injectable cardiac stimulator
Without intervention, cardiac arrhythmias pose a risk of fatality. However, timely intervention can be challenging in environments where transporting a large, heavy defibrillator is impractical, or emergency surgery to implant cardiac stimulation devices is not feasible. Here, we introduce an injectable cardiac stimulator, a syringe loaded with a nanoparticle solution comprising a conductive polymer and a monomer that, upon injection, forms a conductive structure around the heart for cardiac stimulation.
Polycystic Ovary Syndrome: A Hidden Risk for Metabolic and Cardiovascular Diseases?
Women with polycystic ovary syndrome (PCOS) face an increased risk for type 2 diabetes (T2D), metabolic dysfunction–associated steatotic liver disease (MASLD), and cardiovascular disease (CVD), although these risks vary depending on PCOS phenotype.
US News Ranks Top Cardiology, Heart Surgery Hospitals
Cleveland Clinic in Ohio is once again the number-one hospital for cardiology and heart surgery, according to US News & World Report latest rankings.
In the magazine's 2023-2024 list, Cedars-Sinai Medical Center, Los Angeles, California, takes over the number-two spot from Mayo Clinic, Rochester, Minnesota, which drops to No. 3. Cedars-Sinai held the number-three spot on last year's rankings.
Career paths for cardiologists in industry: pharmaceutical, medical insurance, health technology and management consulting
Cardiologists have opportunities to transition to different roles outside of traditional clinical care. In this article, we describe the potential opportunities for cardiologists in pharmaceutical, medical insurance, health technology and management consulting. We highlight some unique considerations for each industry and discuss a strategic approach to engage in these opportunities.
New AHA Statement on Ischemia After Cardiac Surgery
The American Heart Association (AHA) outlines "considerations" on the management of acute postoperative myocardial ischemia (PMI) after cardiac surgery in a scientific statement.
New ESH Hypertension Guidelines Aim for Simplified Message
The European Society of Hypertension (ESH) has released updated and expanded guidelines for the management of hypertension.
The international activities of the Cardioprogress Foundation are expanding
The Cardioprogress Foundation expands its international activities. A register of 7 thousand experts and an opinion of leaders from 46 countries of the world has been created.
Innovative technologies in medicine. International Congress DATS 2023 (Baku, Azerbaijan)
From June 17 to June 22, 2023, the International Congress DATS 2023 was held in the capital of Azerbaijan in Baku, organized by the Tabib (State Administration for Medical Territorial Services of Azerbaijan).
WHO Advises Against Nonsugar Sweeteners for Weight Control
A new guideline from the World Health Organization (WHO) on nonsugar sweeteners (NSSs) recommends not using them to control weight or reduce the risk for diabetes, heart disease, or cancer. These sweeteners include aspartame, acesulfame K, advantame, saccharine, sucralose, stevia, and stevia derivatives.
Keynote presentation «T2DM and Coronary Heart Disease». Prof Mamedov Mekhman
On May 24-25, 2023, the anniversary International Heart Congress in a hybrid regime was held in Tokyo (Japan).
Speakers from 25 countries of the world took part in the scientific program. The key presentation by Professor Mekhman Mamedov (Moscow, Russia) was devoted to the features of coronary artery revascularization and life prognosis in patients with diabetes mellitus and coronary heart disease. The lecture covered issues on the prevalence of diabetes in the world, the relationship with cardiovascular diseases and the prevention of complications.